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Abstract
Background: Previous studies demonstrated a modest association between C-Reactive Protein
(CRP), stenosis of carotid artery, and carotid Intima-Media Thickness (IMT) in general population.
During present study, we aimed to evaluate the relationship between High Sensitivity C-Reactive
Protein (hsCRP) and Common Carotid Intima-Media Thickness (CCIMT) in patients who candidate
for Coronary Artery Bypass Grafting (CABG).
Methods: The study subjects were enrolled from patients with coronary arteries disease referred
from Shahid Madani Hospital (Tabriz, Iran), who have been candidate for elective CABG from
January 2005 to August 2007. The common carotid arteries were evaluated with high-resolution
B-mode ultrasonography using a 7.5- MHz linear-array transducer to determine the IMT and grade
of stenosis. Serum hsCRP level was measured using commercially available enzyme linked
immunosorbent assay kit.
Results: Finally, information of 176 CABG candidates was analysed. The mean age of participants
was 62.71 ± 9.45 years with 1.63 male to female ratio. The mean of CCIMT was 0.69 ± 0.54 mm.
Although there was no significant correlation between serum hsCRP level and CCIMT in patients
without carotid stenosis (p=0.113, r=0.186), participants with common carotid artery stenosis had
higher levels of serum hsCRP than participants without stenosis (2.42+/-1.30 vs. 1.20+/-0.97 mg/dl;
p=0.009).
Conclusion: Study results showed that there was no correlation between serum hsCRP level and
CCIMT in patients without carotid stenosis, but patients with common carotid artery stenosis had
higher levels of serum hsCRP than patients without stenosis.  
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Background
Assessment of carotid arteries stenosis and Intima-Media
Thickness (IMT) by high resolution B-mode ultrasonogra-
phy have been shown correlated with prevalence of cardi-
ovascular disease, myocardial infarction, and stroke [1-3].
Some previous studies reported higher risk of myocardial
infarction and stroke for patients who had higher levels of
carotid arteries IMT [3,4]. In addition to these reports,
results of other investigators demonstrated a modest asso-
ciation between C-Reactive Protein (CRP) and carotid
artery stenosis and IMT [1,5,6]. As we know from previous
studies, atherosclerosis considered to reflect chronic
inflammation in arterial walls [7,8]. Patients cancidate for
Coronary Artery Bypass Grafting (CABG) have higher
level of atherosclerosis, so we aimed to determine the
Common Carotid Intima-Media Thickness (CCIMT),
High Sensitivity C-Reactive Protein (hsCRP) level, and
their relationship in CABG candidates.
Methods
Study population
The study subjects were enrolled from consecutive
patients of the Shahid Madani Hospital (Tabriz, Iran),
who have been candidate for elective CABG from January
2005 to August 2007. In our referral center, all of CABG
candidates underwent carotid and femoral arteries Dop-
pler study, preoperatively.
Patients who had carotid endartrectomy, collagen-vascu-
lar diseases, diabetes, infection diseases history during
recent month, inflammatory gastroenterology diseases,
multiple sclerosis, liver diseases, end stage renal disease
and previous stroke were excluded. The base-line exami-
nation included a medical history and laboratory testing.
Ethical consideration
The study was performed according to the guidelines of
Helsinki declarartion and approved by the Tabriz Univer-
sity of Medical Sciences Ethics Committee. All participants
gave informed consent before including to the study.
Carotid ultrasonographic evaluation
The common carotid arteries were evaluated with high-
resolution B-mode ultrasonography using a 7.5- MHz lin-
ear-array transducer (Hitachi model EUB-525; Hitachi
Medical Corp., Tokyo, Japan) to determine the IMT, site of
plaques, and stenosis grade. Participants were examined
in a supine position, with the head in the axis of the body
slightly tilted to the either side. The IMT was measured in
common carotid artery at sites 1.0 and 3.0 cm proximal
from the beginning of carotid bulb and at the bottom of
the bulb. The IMT was defined as the distance between
two parallel echogenic lines corresponding to the blood-
intima and media-adventitia interfaces. The average value
of the 3 points was calculated for each side and the largest
value (maximum IMT) was used for analysis.
The common carotid arteries were scanned cross-section-
ally and longitudinally. All ultrasound measurements
were recorded in end diastole and were measured by the
investigator blinded to patients' clinical state. Plaque was
defined as a regional intimal thickening, more than 1.2
mm in IMT height. In patients with plaque, carotid artery
stenosis was graded using the peak systolic velocity meas-
ured after the plaque site according to the Society of Radi-
ologists in Ultrasound Consensus Criteria [9].
Serum hsCRP assay
At baseline examination, a blood sample from every par-
ticipant was drawn and centrifuged at 1500 rpm for 5
minutes, and then the serum samples were stored at -
70°C. All of samples were thawed together, and hsCRP
was determined using commercially available enzyme
linked immunosorbent assay kit (Monobind, Inc., Lake
Forest, CA, USA; Lot Num: EIA-31K2A1).
Statistical methods
Data analysis was performed using the SPSS package ver-
sion 13 (Chicago, IL, USA). Continuous variables were
compared between groups using parametric independent
sample  t-test, and oneway-ANOVA, or nonparametric
Man-Whitney U test, and Kruskal walls. X2 test also was
used to analysis significant difference of categorized data.
Pearson correlation and multiple regression were applied
to evaluate the relationship of hsCRP level with CCIMT in
patients without stenosis. A value of p < 0.05 was consid-
ered significant.
Results
Finally, information of 176 CABG candidates was ana-
lysed. Demographic charcterstics of participants were
listed in Table 1. Frequency of various grades of common
carotid stenosis was shown in Table 2 based on right and
left sides. Figure 1 demonstrated frequency of common
carotid artery stenosis in study population. The mean of
CCIMT was 0.69 ± 0.54 mm.
Although there was no significant correlation between
serum hsCRP level and CCIMT (p = 0.113, r = 0.186), par-
ticipants with stenosis had higher levels of serum hsCRP
than participants without stenosis in common carotid
artery (2.42 ± 1.30 vs. 1.20 ± 0.97 mg/dl; p = 0.009).
In comparison of serum hsCRP levels among the various
stenosis grades of common carotid artery, there were no
significant difference between patients with < 50% steno-
sis, 50–60% stenosis, and 70-to near occlusion (p > 0.05;
Table 3).Cardiovascular Ultrasound 2008, 6:23 http://www.cardiovascularultrasound.com/content/6/1/23
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There was a direct linear correlation between age and
CCIMT (p = 0.016, r = 0.239) in participants whitout ste-
nosis.
Discussion
This study examined the association of hsCRP with
CCIMT. Study results showed that there was no correla-
tion between hsCRP and CCIMT in CABG candidates with
subclinical atherosclerosis. Despite this fact, patients with
common carotid artery stenosis had higher levels of
hsCRP than patients without stenosis. During present
study, we strove to control conventional cardiovascular
risk factors and diseases which may be affected hsCRP
level. Furthermore, this study showed a lower incidence of
severe carotid stenosis in Iranian population who candi-
date for CABG; like previous report of Tarzamni et al. for
Iranian [10], and in contrast to the previous studies for
other populations [11-14].
Several epidemiological studies have shown a link
between serum hsCRP level and subsequent cardiovascu-
lar disease in general population [15-19]. In respect to the
carotid atherosclerosis, an association between CRP levels
and the presence of carotid plagues has been demon-
strated by univariate analysis in a prospective studies con-
ducted in general community, or in healthy middle aged
women with a smoking history [20-22]. However, this
relationship between IMT and CRP level appeared to be
largely dependant on age or the presence of other cardio-
vascular risk factors. In contrast to the previous studies
finding, other studies which carried out under controlled
criteria failed to show a relation between CRP and carotid
IMT and plaque formation [23,24].
To the best of our knowledge, this study is the first one
that evaluated relationship of hsCRP and CCIMT among
the CABG candidates. Study findings, in contrary with
some previous reports [6,25], demonstrated that elevated
level of hsCRP was not associated with increased IMT.
While patients with carotid artery stenosis had higher
level of serum hsCRP, there was not statistcally significant
difference between various grades of stenosis. As we
know, patients who candidate for CABG have higher
grades of atherosclerosis in coronary arteries. Today,
atherosclerosis consider as a chronic inflammatory proc-
ess [7,8], and innate and adaptive immune responses par-
ticipate in several phases of atherosclerosis [26]. CRP is a
component of innate immunity that is actively partici-
pates in inflammatory process. Recent evidences have sug-
gested a possible direct pathogenic role for CRP in
atherosclerosis process and plaque formation [27-29] and
increasing of CRP level promote arterial atherosclerosis.
Alternatively, it may merely be an epiphenomena and an
indicator of systemic inflammation which itself is associ-
ated with atherosclerosis.
Furthermore, some of conventional cardiovascular risk
factors such as smoking, obesity may act to increase
atherosclerosis partly through increasing systemic inflam-
mation. The systemic inflammatory response is also
increased in smokers according to the pack pear year of
smoking [23]. This may be related to both of bacterial
endotoxin and the increased risk of respiratory tract infec-
tion seen in smokers [30]. Therefore, elevated CRP may
merely reflect an exaggerated inflammatory response asso-
ciated with these conventional cardiovascular risk factors
[31,32].
As well-known ligand of phosphorylcholine residues,
CRP binds avidly to oxidized low-density lipoproteins
and may induce foam cell formation in atherosclerosis
[33,34]. In this case and by considering the patients with
Table 1: Demographic characteristics of participants.
Variable Value
Age (years) 62.71 ± 9.45
BMI (Kg/m2) 28.31 ± 3.74
Gender Male 109 (61.93%)
Female 67 (38.07%)
Male/female ratio 1.63
Smoking history Male 58 (54.12%)
Female 6(8.95%)
Smoking (Current/Former) Male 13(11.92%)/45(42.19%)
Female 0(0.0%)/6(8.95%)
Systolic blood pressure (mm Hg) 148.32 ± 24.43
Diastolic blood pressure (mm Hg) 91.54 ± 18.26
Anti-hypertensive therapy 70.45%
Lipid-lowering agent intake 46.02%
Frequency of common carotid artery stenosis in study popu- lation Figure 1
Frequency of common carotid artery stenosis in study popu-
lation.Cardiovascular Ultrasound 2008, 6:23 http://www.cardiovascularultrasound.com/content/6/1/23
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carotid artery stenosis had higher serum hsCRP levels, the
CRP effect might be confirmed clinically by study results.
Despite these findings, one of our study limitations was
limited population. So, we struggled to use proper statis-
tical tests to analysis data and appropriate inclusion and
exclusion criteria to control any factors may address any
bias.
Conclusion
In conclusion, our study results showed that there was no
correlation between serum hsCRP level and intima-media
thickness of common carotid in patients without stenosis,
but patients with common carotid artery stenosis had
higher levels of serum hsCRP than patients without sten-
osis.
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